IRIS
GALLO CANTAFIO, MARIA EUGENIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.285
AS - Asia 748
EU - Europa 429
SA - Sud America 137
Continente sconosciuto - Info sul continente non disponibili 83
AF - Africa 17
OC - Oceania 3
Totale 2.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.227
SG - Singapore 375
IT - Italia 238
CN - Cina 150
BR - Brasile 100
VN - Vietnam 83
DE - Germania 52
IN - India 52
GB - Regno Unito 37
HK - Hong Kong 36
CA - Canada 35
FI - Finlandia 21
SE - Svezia 21
NL - Olanda 13
AR - Argentina 12
BD - Bangladesh 11
MX - Messico 9
PL - Polonia 7
EU - Europa 6
RU - Federazione Russa 6
CL - Cile 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
VE - Venezuela 5
YE - Yemen 5
AT - Austria 4
CR - Costa Rica 4
EG - Egitto 4
ES - Italia 4
ID - Indonesia 4
IQ - Iraq 4
MA - Marocco 4
RO - Romania 4
AU - Australia 3
CH - Svizzera 3
FR - Francia 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
DO - Repubblica Dominicana 2
IR - Iran 2
JM - Giamaica 2
MY - Malesia 2
PR - Porto Rico 2
UA - Ucraina 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
GM - Gambi 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TR - Turchia 1
TW - Taiwan 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 2.626
Salva come PNG Salva come JPEG
Città #
San Jose 254
Singapore 163
Ashburn 133
Chandler 85
Santa Clara 64
Dallas 57
Council Bluffs 47
Bengaluru 42
Hefei 42
Munich 40
Catanzaro 38
Hong Kong 36
Ho Chi Minh City 34
Chicago 32
Milan 31
Beijing 29
Princeton 25
Lawrence 24
London 24
Phoenix 22
Hanoi 19
Los Angeles 17
Turku 16
New York 15
Rome 13
São Paulo 13
Wilmington 11
Des Moines 10
Naples 10
Ottawa 10
Bari 9
Reggio Calabria 9
Boardman 7
Brooklyn 7
Montreal 7
Manchester 6
Rio de Janeiro 6
San Nicola Manfredi 6
Warsaw 6
Frankfurt am Main 5
Helsinki 5
Olomouc 5
San Francisco 5
Sanaa 5
The Dalles 5
Biên Hòa 4
Cosenza 4
Da Nang 4
Haiphong 4
Siano 4
Ahmedabad 3
Amman 3
Berlin 3
Boston 3
Buffalo 3
Can Tho 3
Castrovillari 3
Charlotte 3
Chennai 3
Columbus 3
Giugliano in Campania 3
Lima 3
Nairobi 3
Norwalk 3
Praia Grande 3
Redwood City 3
Salt Lake City 3
San Antonio 3
San José 3
San Prisco 3
Stockholm 3
Tongi 3
Vienna 3
6th of October City 2
Amsterdam 2
Atlanta 2
Bacoli 2
Bady Bassitt 2
Belo Horizonte 2
Calgary 2
Casablanca 2
Ceglie Del Campo 2
Cortale 2
Dhaka 2
Florianópolis 2
Grottaglie 2
Guayaquil 2
Horia 2
Irsina 2
Itabira 2
Jakarta 2
Jeddah 2
Kansas City 2
Kota Samarahan 2
Las Vegas 2
Markham 2
Mexico City 2
Orem 2
Osijek 2
Porto Alegre 2
Totale 1.592
Salva come PNG Salva come JPEG
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 116
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells 99
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells 91
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 84
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 83
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 81
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 80
Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma 77
MiR-34a Replacement As a Novel Therapeutic Approach for Multiple Myeloma: Preclinical In Vitro and In Vivo Evidence 75
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 74
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 73
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells (CO-FIRST AUTHOR) 70
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 69
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 69
Influence of the fabrication accuracy of hot-embossed PCL scaffolds on cell growths 69
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells (CO-FIRST AUTHOR) 63
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 61
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma 58
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 57
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity (CO-FIRST AUTHOR) 57
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates 57
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma 56
Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma 55
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence 55
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 54
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 52
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations 52
Non-Coding RNA-Dependent Regulation of Mitochondrial Dynamics in Cancer Pathophysiology 51
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic State 51
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 48
Non-Coding RNA-Dependent Regulation of Mitochondrial Dynamics in Cancer Pathophysiology 48
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cells 47
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 46
Lipid metabolic vulnerabilities of multiple myeloma (CO-FIRST AUTHOR) 46
Lipid metabolic vulnerabilities of multiple myeloma (CO-FIRST AUTHOR) 45
Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma 44
null 43
Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model 41
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma 40
New Insights for Polyphenolic Compounds as Naturally Inspired Proteasome Inhibitors (CO-FIRST AUTHOR) 39
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 36
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo 32
null 31
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma (FIRST AUTHOR) 29
Cytogenetic and molecular characterization of an atypical ETP-ALL case with BCL2 dependency: therapeutic implications for Venetoclax use 23
Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities 20
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 15
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 15
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax 13
null 11
null 1
Totale 2.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202299 0 0 0 15 7 5 9 14 13 20 15 1
2022/2023259 48 16 18 10 28 24 3 20 42 15 19 16
2023/2024143 36 26 6 11 7 33 5 0 0 1 7 11
2024/2025531 55 17 21 25 29 77 26 15 45 39 76 106
2025/20261.234 93 108 129 155 145 75 164 106 100 112 38 9
2026/2027326 24 67 159 76 0 0 0 0 0 0 0 0
Totale 2.702